🔎 Trials Near Me

Akèy › Twoub depresif majè › Kalifòni › Glendale

Etid klinik pou Twoub depresif majè nan Glendale, CA

12 etid pou Twoub depresif majè ap chèche patisipan nan sit nan ak bò kote Glendale (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

Ap rekriteFaz 3
  • Behavioral Research Specialists LLC, Glendale
Laj 18 a 74 · Tout sèks · Mizajou Oct 1, 2026 · NCT07573176

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Ap rekriteFaz 3
  • Behavioral Research Specialists LLC, Glendale
Laj 18 a 74 · Tout sèks · Mizajou Sep 25, 2026 · NCT06559306

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Ap rekriteFaz 3
  • Behavioral Research Specialists, LLC, Glendale
Laj 18 a 85 · Tout sèks · Mizajou Sep 25, 2026 · NCT06793397

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

Ap rekriteFaz 2
  • Seaport Investigator Site, Glendale
Laj 18 a 65 · Tout sèks · Mizajou Sep 14, 2026 · NCT07065240

ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response

Ap rekriteFaz 2
  • Behavioral Research Specialists, LLC, Glendale
Laj 18 a 65 · Tout sèks · Mizajou Sep 14, 2026 · NCT07284667

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 3
  • Neurocrine Clinical Site, Glendale
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT06911112

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

Ap rekriteFaz 3
  • Behavioral Research Specialists, Llc, Glendale
Laj 18 a 74 · Tout sèks · Mizajou Aug 3, 2026 · NCT06775379

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 3
  • Neurocrine Clinical Site, Glendale
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT06966401

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

Ap rekriteFaz 3
  • Clinical Research Site, Glendale
Laj 18 a 65 · Tout sèks · Mizajou Jul 24, 2026 · NCT07484217

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

Ap rekriteFaz 2
  • Behavioral Research Specialists, LLC, Glendale
Laj 18 a 65 · Tout sèks · Mizajou May 11, 2026 · NCT06524830

Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)

Ap rekriteFaz 2
  • Autobahn Site #124, Glendale
Laj 18 a 65 · Tout sèks · Mizajou Jan 20, 2026 · NCT06633016

Study of ALTO-300 in MDD

Ap rekriteFaz 2
  • Site 217, Glendale
Laj 18 a 70 · Tout sèks · Mizajou Jul 24, 2025 · NCT05922878

Etid Twoub depresif majè nan lòt vil

Lòt etid nan Glendale

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.